| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b19b1f547f631e81abdd30beec341820 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-688
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-6615
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-688 |
| filingDate |
2016-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ac014ea13b27c414221a18bb74572ac |
| publicationDate |
2018-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2018029505-A1 |
| titleOfInvention |
Cer-001 therapy for treating familial primary hypoalphalipoproteinemia |
| abstract |
Methods for treating a subject by administering CER-001 to the subject according to an induction regimen comprising multiple doses of CER-001 administered five or more days apart and subsequently administering CER-001 to the subject according to a maintenance regimen. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11752163-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021209823-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021209808-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021209822-A1 |
| priorityDate |
2016-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |